Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 7, 2011 - Issue 6
Submit an article Journal homepage
185
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pharmacokinetic evaluation of eltoprazine

Sharon B WigalProfessor of pediatrics at the University of California, Irvine, Director of clinical trials, Child Development Center, Department of Pediatrics, 19722 MacArthur Blvd, Irvine, CA 92612, USA+1 949 824 1833; +1 949 824 1811; [email protected]
, PhD &
Sophie DuongClinical research coordinator at the University of California, Irvine, Child Development Center, Department of Pediatrics, 19722 MacArthur Blvd, Irvine, CA 92612, USA
, BA
Pages 775-781 | Published online: 06 May 2011

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Andrea Fabbrini & Andrea Guerra. (2021) Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia. Journal of Experimental Pharmacology 13, pages 469-485.
Read now
Antonio Molina-Carballo, Ana Checa-Ros & Antonio Muñoz-Hoyos. (2016) Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opinion on Therapeutic Patents 26:7, pages 799-814.
Read now
Dmitry Petrov, Ignacio Pedros, Maria Luisa de Lemos, Mercè Pallàs, Anna Maria Canudas, Alberto Lazarowski, Carlos Beas-Zarate, Carme Auladell, Jaume Folch & Antoni Camins. (2014) Mavoglurant as a treatment for Parkinson’s disease. Expert Opinion on Investigational Drugs 23:8, pages 1165-1179.
Read now

Articles from other publishers (2)

Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori & Francisco Romo-Nava. (2018) Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa. CNS Drugs 33:1, pages 31-46.
Crossref
Per Svenningsson, Carl Rosenblad, Karolina af Edholm Arvidsson, Klas Wictorin, Charlotte Keywood, Bavani Shankar, David A. Lowe, Anders Björklund & Håkan Widner. (2015) Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study. Brain 138:4, pages 963-973.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.